Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patterns.

Tesch, H., Ulshöfer, T., Vehling-Kaiser, U., Ottillinger, B., Bulenda, D., Turner, M., 2015.

Oncol Res Treat 38, 146–152. doi:10.1159/000381318

Studie: HEXAFIL; Indikation: Supportivtherapie; Jahr: 2015; Veranstaltung: -; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com